A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy [PDF]
The treatment of periodontitis can be very challenging due to its complex etiologies. A new pharmacologic strategy entitled “host-modulation therapy,” has been introduced to improve periodontal treatment outcomes.
Dengke Li +13 more
doaj +3 more sources
Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis [PDF]
Background Osteoporosis, a systemic skeletal disease, seriously affects the quality of life in postmenopausal women. As one type of cathepsin K (CatK) inhibitor, odanacatib (ODN) is a fresh medication for osteoporosis.
Jiaxuan Li +5 more
doaj +3 more sources
Process-Induced Crystal Surface Anisotropy and the Impact on the Powder Properties of Odanacatib [PDF]
Crystalline active pharmaceutical ingredients with comparable size and surface area can demonstrate surface anisotropy induced during crystallization or downstream unit operations such as milling.
Isha Bade +7 more
doaj +3 more sources
Do matrix metalloproteinase and cathepsin K inhibitors work synergistically to reduce dentin erosion? [PDF]
Objectives To evaluate the effects of matrix metalloproteinase (MMP) and cathepsin K (catK) inhibitors on resistance to dentin erosion. Methodology A total of 96 dentin specimens (3×3×2 mm) were prepared and randomly assigned into four groups (n=24 ...
Xiujiao LIN +4 more
doaj +5 more sources
Real-time analysis of osteoclast resorption and fusion dynamics in response to bone resorption inhibitors [PDF]
Cathepsin K (CatK), an essential collagenase in osteoclasts (OCs), is a potential therapeutic target for the treatment of osteoporosis. Using live-cell imaging, we monitored the bone resorptive behaviour of OCs during dose-dependent inhibition of CatK by
Preety Panwar +5 more
doaj +4 more sources
Odanacatib Coating Supports Osseointegration of Implants: A Preclinical Study. [PDF]
Introduction Odanacatib (ODN), a cathepsin K inhibitor, is a drug that reduces bone resorption while preserving bone formation. ODN was initially developed for the treatment of postmenopausal osteoporosis, but further development as a systemic medication
Dos Santos Sanches N +10 more
europepmc +2 more sources
CU Cilia – an application for image analysis by machine learning – reveals significance of cysteine cathepsin K activity for primary cilia of human thyroid epithelial cells [PDF]
IntroductionCysteine cathepsins K and L are crucial for proper thyroid function in mice. Inhibition of cysteine peptidases in rodent thyroid epithelial cells in vitro results in loss of primary cilia, highlighting the significance of proteolysis for ...
Maren Rehders +8 more
doaj +2 more sources
Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women [PDF]
Osteoclasts are specialized cells that initiate the process of bone resorption, which has two phases, dissolution of the mineral component and degradation of the organic matrix, in which cathepsin K plays a key role.
José Luis Pérez-Castrillón +4 more
doaj +4 more sources
Cellular and molecular mechanisms of osteoporosis: current concepts and future direction treatment [PDF]
The article presents review of literature dedicated to the contemporary view on the cellular-molecular mechanisms of the bone remodeling and pathogenesis of the osteoporosis. The discovery of the cytokine RANKL-RANK-OPG system and significant role of the
A. T. Dolzhenko, S. Sagalovsky
doaj +3 more sources
Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering Methods [PDF]
Micronized particles are commonly used to improve the content uniformity (CU), dissolution performance, and bioavailability of active pharmaceutical ingredients (API).
Zijian Wang +6 more
doaj +2 more sources

